| Autor: |
Aguiar-Bujanda D; Servicio de Oncología Médica, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain. dagubuj@gobiernodecanarias.org, Quiñones-Morales I, Camacho-Galán R, Llorca-Martínez I, Rivero-Vera JC, Bohn-Sarmiento U, Aguiar-Morales J |
| Jazyk: |
angličtina |
| Zdroj: |
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2007 Jul; Vol. 9 (7), pp. 471-2. |
| DOI: |
10.1007/s12094-007-0088-2 |
| Abstrakt: |
Non-Hodgkin's lymphoma (NHL) of the gastrointestinal (GI) tract is the most common extranodal lymphoma, accounting for approximately 40% of all extranodal NHLs. Initial treatment of duodenal lymphoma includes surgery, chemotherapy and radiotherapy, alone or in combination. Here, we present a case of stage I primary duodenal follicular lymphoma (FL) showing a complete response after rituximab therapy. Rituximab alone can be an effective alternative treatment for duodenal FL. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink